Notice of Proposed Sale · 144
Century Therapeutics, Inc.
IPSCNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Century Therapeutics, Inc.
- Issuer CIK
- 0001850119
- SEC file number
- 001-40498
- Phone
- 215-981-4000
- Person for whose account securities are to be sold
- Russotti Gregory
- Relationships to issuer
- Officer
- Street
- 25 N 38TH STREET, 12TH FLOOR
- City
- PHILADELPHIA
- State / country code
- PA
- Postal code
- 19104
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 534 | 1,094.43 | 181,075,321 | 09/08/2026 | NASDAQ | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 09/04/2026 | Restricted Stock Vesting | Issuer | 534 | N | 09/04/2026 | Compensation |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Gregory Russotti | Common | 06/08/2026 | 524 | 1,106.01 |
| Gregory Russotti | Common | 06/12/2026 | 2,584 | 5,767.75 |
Seller — prior-sale row 1, entry 1
- Name
- Gregory Russotti
- Street
- 25 N 38th Street 12th Floor
- City
- Philadelphia
- State / country code
- PA
- Postal code
- 19104
Seller — prior-sale row 2, entry 1
- Name
- Gregory Russotti
- Street
- 25 N 38th Street 12th Floor
- City
- Philadelphia
- State / country code
- PA
- Postal code
- 19104
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Notice signature
- Notice date
- 09/08/2026
- Signed
- /s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gregory Russotti
Company context
Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of iPSC-derived cell therapies with the potential to meaningfully address autoimmune diseases, including T1D, and cancer. Century's therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. For more information on Century Therapeutics, please visit www.centurytx.com and connect with us on LinkedIn.